We say it all the time, the biotech sector is ever changing as FDA guidelines and patient needs evolve. As the landscape continues to shift among large biotechs and small startups, seeing that 38 of the 59 new therapies approved in 2018 came from small or emerging companies is certainly an impactful statistic! The biotech […]
Industry News
Biotechs getting bigger in late-stage R&D, leaving Big Pharmas behind: report | FierceBiotech
April 25th, 2019 | Industry NewsBringing CAR-T cancer treatments to solid tumors with help from alpacas | FierceBiotech
April 16th, 2019 | Industry NewsWith over 100 Massachusetts based companies focusing on oncology as their primary therapeutic area, over 20 of them are committed to the Car-T treatment option. We love seeing Boston Children’s and MIT join forces to devise a new and innovative approach to overcoming a common hurdle that they all may come to face – and […]
Price hikes, a strategic retreat and 1 big new approval has shaken up the rankings of the 20 most expensive drugs on the planet – Endpoints News
March 27th, 2019 | Industry NewsAnother strong example of how quickly things change in this industry! With over half of the most expensive drug makers headquartered in New England, and so many anticipated new approvals for 2019, all we can do is expect the unexpected and adapt accordingly. It’s been just 4 months since GoodRx released its newly expanded list […]
Connecticut Aims to Grow Its Biotech Industry | BioSpace
February 25th, 2019 | Industry NewsNestled right between the two Biotech hotspots in New York and Boston, planned growth in CT certainly makes sense from a staffing and investment standpoint. The state of Connecticut is embracing a new strategic vision for its biotech sector that could foment an addition of more than 6,000 new jobs over the next 10 years […]
Top 20 Life Science Startups to Watch in 2019 | BioSpace
January 9th, 2019 | Industry News11 of the top 20 companies are located in the Greater Boston Area! Source: Top 20 Life Science Startups to Watch in 2019 | BioSpace
The 2018 breakdown on a chart-topping set of new drug approvals — and the 5 big things we learned from it – Endpoints News
January 2nd, 2019 | Industry NewsWith 90+ total FDA approvals and record breaking IPOs, 2018 was an unprecedented year for the biotech industry. Here’s to an even bigger 2019 as we look towards the year ahead! 2018 will go down as a remarkable year for biopharma R&D, and not just because the industry posted an all-time record high in new […]
Fresenius Medical Care North America Contributes Record Funding to National Kidney Foundation | BioSpace
December 21st, 2018 | Industry NewsIt is so amazing to see large companies giving back in such a large way. Great work and great things coming from our friends over at Frenova and Fresenius! Fresenius Medical Care North America (FMCNA), the world’s largest provider of dialysis products and services, raised more than $800,000 for the National Kidney Foundation (NKF) centerpiece […]
Top 12 Life Sciences Companies Hiring Now for Candidates Like You | BioSpace
December 14th, 2018 | Industry NewsLocally and nationally, the biopharma industry never sleeps! Now is a great time of year to assess what 2019 is going to look like for you on a hiring front for managers, and on a career front for prospective candidates. We’d love to work with you to help you find what you’re looking for! Winter […]
PhRMA Highlights Impact of Cell and Gene Therapies in New Report | BioSpace
December 11th, 2018 | Industry NewsVery interesting read that dives into how the current pharmaceutical landscape is evolving based on the impact and success of cell and gene therapies. Many of these new research pioneers are right in our backyard here in Beantown! This morning the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that shows there are […]